Zydus Cadila has received tentative approval from the USFDA to market Clofarabine Injection 20mg/20ml vials. The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003 - 04.
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. It is the only Indian pharma company to launch its own patented NCE - Lipaglyn, the world’s first drug to be approved for the treatment of diabetic dyslipidemia.
